Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs

In a victory for GlaxoSmithKline PLC, a legal adviser at the European Court of Justice has ruled that branded drug makers should be allowed to restrict supplies of patented drugs to...

Already a subscriber? Click here to view full article